» Articles » PMID: 24970368

Sine Oculis Homeobox Homolog 1 Promotes DNA Replication and Cell Proliferation in Cervical Cancer

Overview
Journal Int J Oncol
Specialty Oncology
Date 2014 Jun 28
PMID 24970368
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant proliferation is the fundamental trait of tumor cells. The initiation of DNA replication represents a key process for cell proliferation, and has a marked impact on tumorigenesis and progression. Here we report that Sine oculis homeobox homolog 1 (SIX1) functions as a master regulator in DNA replication of cervical cancer cells. The expression of SIX1 was induced by the E7 oncoprotein of human papillomaviruses in cervical intraepithelial neoplasia and cervical cancer. The increase of SIX1 expression resulted in the upregulation of multiple genes related to the initiation of DNA replication, including the genes coding for the proteins in minichromosome maintenance complex (MCM2, MCM3, MCM6), DNA polymerase α-primase complex (POLA1, PRIM1, PRIM2), clamp loader (RFC3, RFC4, RFC5), DNA polymerase δ complex (POLD3) and DNA polymerase ε complex (POLE2). In line with this, the increase of SIX1 expression enhanced DNA synthesis, accelerated G1 to S phase progression, and promoted the proliferation of cervical cancer cells and the growth of cervical cancer. Consistently, knockdown of SIX1 could hamper DNA synthesis, slow down G1 to S phase progression, and suppress tumor cell proliferation and tumor growth. Importantly, SIX1 could more efficiently promote anchorage-independent cell growth. These results suggest that the increase of SIX1 expression could promote tumorigenesis, progression and invasive growth of cervical cancer by promoting DNA replication, and that targeting SIX1 may have significant therapeutic value in cervical cancer treatment.

Citing Articles

RFC3 Knockdown Decreases Cervical Cancer Cell Proliferation, Migration and Invasion.

Koh J, Park S Cancer Genomics Proteomics. 2024; 22(1):127-135.

PMID: 39730174 PMC: 11696326. DOI: 10.21873/cgp.20493.


POLE2 silencing inhibits the progression of colorectal carcinoma cells via wnt signaling axis.

Jian W, Zhang L Cancer Biol Ther. 2024; 25(1):2392339.

PMID: 39155507 PMC: 11340749. DOI: 10.1080/15384047.2024.2392339.


High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5.

Xu S, Zhong F, Jiang J, Yao F, Li M, Tang M Technol Cancer Res Treat. 2024; 23:15330338241271906.

PMID: 39110418 PMC: 11307364. DOI: 10.1177/15330338241271906.


Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics.

Bian Z, Benjamin M, Bialousow L, Tian Y, Hobbs G, Karan D Heliyon. 2024; 10(12):e33204.

PMID: 39022099 PMC: 11252760. DOI: 10.1016/j.heliyon.2024.e33204.


The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.

Jiang D, Zhang H, Yin B, He M, Lu X, He C Comb Chem High Throughput Screen. 2024; 27(13):1984-1998.

PMID: 38963027 DOI: 10.2174/0113862073273633231113060429.